Glycosaminoglycans: Carriers and Targets for Tailored Anti-Cancer Therapy

Aikaterini Berdiaki1, Monica Neagu2, Eirini-Maria Giatagana1

  • 1Laboratory of Histology-Embryology, School of Medicine, University of Crete, 71003 Heraklion, Greece.

Biomolecules
|April 3, 2021
PubMed

Insights

Glycosaminoglycans (GAGs) undergo significant structural changes during cancer progression, correlating with malignancy. These GAG alterations offer promising therapeutic targets and drug delivery strategies for cancer treatment.

Area of Science:

  • Biochemistry
  • Oncology
  • Biomaterials Science

Background:

  • The tumor microenvironment (TME) comprises diverse cells and extracellular matrix (ECM) components.
  • Glycosaminoglycans (GAGs), vital ECM and cell membrane constituents, are notably altered in cancerous tissues.
  • Changes in GAG structure, including sulfation patterns, molecular weight, and distribution, are linked to cancer progression and malignant transformation.

Purpose of the Study:

  • To review recent advancements and the extensive potential of glycosaminoglycans (GAGs) in cancer therapy.
  • To explore the dual role of GAGs as therapeutic targets and as carriers for cancer therapeutics.
  • To discuss the implications of GAG alterations in tumorigenesis for drug development.

Main Methods:

  • Comprehensive literature review of GAGs in cancer.
  • Analysis of GAG structural modifications during cancer evolution.
  • Evaluation of GAG-based therapeutic strategies and drug delivery systems.

Main Results:

  • GAG fine structure modifications, particularly sulfation patterns, are directly correlated with malignant transformation.
  • Distinct alterations in GAG molecular weight, distribution, and composition occur during cancer development.
  • GAGs exhibit unique properties making them suitable for both targeting cancer and delivering therapeutics.

Conclusions:

  • GAGs represent promising effectors and targets for novel anticancer therapies.
  • The specific properties of GAGs facilitate their use in targeted drug delivery systems for cancer treatment.
  • Continued research into GAGs holds significant potential for advancing cancer drug development and therapeutic strategies.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Glycosaminoglycans01:23

Glycosaminoglycans

Glycosaminoglycans (GAGs), also known as mucopolysaccharides, are long and linear polymers comprising of specific repeating disaccharides - the amino sugar that can be N-acetylglucosamine or N-acetylgalactosamine, and a uronic acid that is usually glucuronic acid or iduronic acid.
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
5.8K
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
818
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.5K
Protein Glycosylation01:25

Protein Glycosylation

Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
8.3K